ArriVent BioPharma, Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
HHLR ADVISORS, LTD. | 05/15/2025 | 4.48 M | $82.92 M | 0.00% | 14.25% |
ORBIMED ADVISORS LLC | 05/15/2025 | 3.03 M | $55.98 M | 0.00% | 9.62% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 2.34 M | $43.22 M | 4.07% | 6.90% |
BLACKROCK, INC. | 05/02/2025 | 2.14 M | $39.56 M | 0.22% | 6.31% |
FMR LLC | 05/12/2025 | 2.08 M | $38.43 M | -1.07% | 6.13% |
05/16/2025 | 2.07 M | $38.20 M | 25.69% | 6.10% | |
OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 2.06 M | $38.08 M | 0.00% | 6.08% |
NOVO HOLDINGS A/S | 05/15/2025 | 1.87 M | $34.62 M | 23.12% | 5.95% |
SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 1.70 M | $31.37 M | 0.00% | 5.39% |
VANGUARD GROUP INC | 05/09/2025 | 1.50 M | $27.80 M | 6.07% | 4.43% |
GENERAL CATALYST GROUP MANAGEMENT, LLC | 04/16/2025 | 1.49 M | $27.64 M | 0.00% | 4.41% |
STATE STREET CORP | 05/15/2025 | 767.74 K | $14.20 M | -5.69% | 2.26% |
SC CHINA HOLDING LTD | 05/13/2025 | 663.31 K | $13.98 M | 0.00% | 1.96% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 614.52 K | $11.37 M | 3.08% | 1.81% |
HIDDEN LAKE ASSET MANAGEMENT LP | 05/15/2025 | 254.37 K | $4.70 B | 37.79% | 0.75% |
NORTHERN TRUST CORP | 05/13/2025 | 237.70 K | $4.40 M | -1.37% | 0.70% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 196.49 K | $3.63 M | -4.79% | 0.58% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 158.06 K | $2.92 M | 200.81% | 0.50% |
WOODLINE PARTNERS LP | 05/15/2025 | 146.37 K | $2.71 M | 0.40% | 0.43% |
MORGAN STANLEY | 05/15/2025 | 121.94 K | $2.25 M | -17.93% | 0.36% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 76.88 K | $1.42 M | -62.91% | 0.23% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 68.23 K | $1.26 M | 0.33% | 0.20% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 61.35 K | $1.13 M | 46.34% | 0.18% |
05/12/2025 | 44.28 K | $818.78 K | 100.00% | 0.13% | |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 41.38 K | $765.14 K | 100.00% | 0.12% |
BARCLAYS PLC | 05/15/2025 | 40.58 K | $751.00 K | -24.14% | 0.12% |
RHUMBLINE ADVISERS | 04/08/2025 | 37.14 K | $686.76 K | 1.23% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 36.79 K | $680.27 K | 106.27% | 0.11% |
MARSHALL WACE, LLP | 05/15/2025 | 35.85 K | $662.88 K | 100.00% | 0.11% |
CITIGROUP INC | 05/12/2025 | 34.17 K | $631.79 K | 0.14% | 0.10% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 29.29 K | $541.48 K | -35.70% | 0.09% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 28.20 K | $521.42 K | 0.00% | 0.08% |
SWISS NATIONAL BANK | 05/12/2025 | 26.40 K | $488.14 K | 0.00% | 0.08% |
ALPS ADVISORS INC | 04/30/2025 | 25.17 K | $465.34 K | -7.65% | 0.07% |
DEUTSCHE BANK AG\ | 05/09/2025 | 23.18 K | $428.65 K | -3.95% | 0.07% |
SG AMERICAS SECURITIES, LLC | 04/15/2025 | 22.68 K | $419.00 K | 92.09% | 0.07% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2025 | 22.27 K | $412.00 K | 100.00% | 0.07% |
SQUAREPOINT OPS LLC | 05/15/2025 | 18.43 K | $340.70 K | 100.00% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 18.07 K | $334.10 K | 22.10% | 0.05% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 18.00 K | $332.82 K | 100.00% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 17.55 K | $324.80 K | 2.52% | 0.05% |
RAFFERTY ASSET MANAGEMENT, LLC | 05/14/2025 | 17.41 K | $321.89 K | -36.23% | 0.05% |
METLIFE INVESTMENT MANAGEMENT, LLC | 05/14/2025 | 17.11 K | $316.36 K | -2.00% | 0.05% |
TUDOR INVESTMENT CORP ET AL | 05/15/2025 | 15.29 K | $282.77 K | 100.00% | 0.05% |
JPMORGAN CHASE & CO | 05/12/2025 | 16.33 K | $301.92 K | 4.11% | 0.05% |
INVESCO LTD. | 05/12/2025 | 15.13 K | $279.75 K | -1.36% | 0.04% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 14.82 K | $274.00 K | 2.25% | 0.04% |
DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 05/16/2025 | 14.38 K | $266.00 K | 100.00% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 13.80 K | $255.22 K | -1.46% | 0.04% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 05/15/2025 | 13.65 K | $252.37 K | 0.00% | 0.04% |
ArriVent BioPharma, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 89 institutional investors and hedge funds held shares of ArriVent BioPharma, Inc. Common Stock. The most heavily invested institutionals were:
HHLR ADVISORS, LTD.: 4.48 M
ORBIMED ADVISORS LLC: 3.03 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 2.34 M
BlackRock, Inc.: 2.14 M
FMR LLC: 2.08 M
Octagon Capital Advisors LP: 2.06 M
92.42% of ArriVent BioPharma, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 28.02 M shares in the last 24 months. This purchase volume represents approximately $571.53 M in transactions.